UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 154

Sortiert nach

A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1707-1716.e2

2019

Volltextzugriff (PDF)

Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-wide Association Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.1078-1089

2017

Volltextzugriff (PDF)

O-7 LIVER TOXICITY OF TYROSINE KINASE INHIBITORS: A DESCRIPTIVE ANALYSIS FROM SLATINDILI NETWORK

Annals of hepatology, 2023-03, Vol.28, p.101017, Article 101017

2023

Volltextzugriff (PDF)

Implementation of a re‐linkage to care strategy in patients with chronic hepatitis C who were lost to follow‐up in Latin America

Journal of viral hepatitis, 2023-01, Vol.30 (1), p.56-63

2023

Volltextzugriff (PDF)

Hepatotoxicidad por esteroides anabólicos androgénicos, reporte de 2 casos en Uruguay

Anales de la Facultad de Medicina (Montevideo, Uruguay : 2013), 2018-12, Vol.5 (2), p.116-122

2018

Volltextzugriff (PDF)

Colangiopatía portal: complicación poco frecuente de la hipertensión portal

Anales de la Facultad de Medicina (Montevideo, Uruguay : 2013), 2017-12, Vol.4 (2), p.112-122

2017

Volltextzugriff (PDF)

Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury

Annals of hepatology, 2024-09, Vol.29 (5), p.101520, Article 101520

2024

Volltextzugriff (PDF)

Mixed Infections Unravel Novel HCV Inter-Genotypic Recombinant Forms within the Conserved IRES Region

Viruses, 2024-04, Vol.16 (4), p.560

2024

Volltextzugriff (PDF)

Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report

BMC infectious diseases, 2021-04, Vol.21 (1), p.387-6, Article 387

2021

Volltextzugriff (PDF)

P-75 UPDATE OF CLINICO-EPIDEMIOLOGICAL CHARACTERISTICS OF PRIMARY BILIAR CHOLANGITIS IN URUGUAY

Annals of hepatology, 2021-09, Vol.24, p.100438, Article 100438

2021

Volltextzugriff (PDF)

Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical Practice

Seminars in liver disease, 2019-07, Vol.39 (3), p.381

2019

Volltextzugriff (PDF)

Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries

Liver international, 2023-08, Vol.43 (8), p.1749-1760

2023

Volltextzugriff (PDF)

Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review

United European gastroenterology journal, 2019-07, Vol.7 (6), p.825-837

2019

Volltextzugriff (PDF)

Diagnóstico no invasivo de la presencia de várices esofágicas en pacientes cirróticos

Acta gastroenterologica latinoamericana, 2014-06, Vol.44 (2), p.108-113

2014

Volltextzugriff (PDF)

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

International journal of molecular sciences, 2016-02, Vol.17 (3), p.313-313

2016

Volltextzugriff (PDF)

Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver

Annals of hepatology, 2021-09, Vol.24, p.100321, Article 100321

2021

Volltextzugriff (PDF)

Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification

Pharmacological research, 2024-01, Vol.199, p.107030-107030, Article 107030

2024

Volltextzugriff (PDF)

Cirrosis biliar primaria: Aspectos clínico- epidemiológicos en una población uruguaya

Acta gastroenterologica latinoamericana, 2013-12, Vol.43 (4), p.288-293

2013

Volltextzugriff (PDF)

Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases

Liver international, 2016-02, Vol.36 (2), p.302-310

2016

Volltextzugriff (PDF)

Syphilitic hepatitis: should it be added to the algorithm of hepatogram alterations? Report of three cases

Acta gastroenterologica latinoamericana, 2020-12, Vol.50 (3)

2020

Volltextzugriff (PDF)

Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients

Disease markers, 2018-01, Vol.2018, p.2514901-9

2018

Volltextzugriff (PDF)

Naturally occurring NS3 resistance-associated variants in hepatitis C virus genotype 1: Their relevance for developing countries

Virus research, 2016-09, Vol.223, p.140-146

2016

Volltextzugriff (PDF)

OP-3 CLINICAL PRESENTATION AND CAUSATIVE AGENTS OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY IN URUGUAY: FIRST DECADE OF EXPERIENCE

Annals of hepatology, 2023-03, Vol.28, p.101052, Article 101052

2023

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(139)

Publikationsform

Artikel
(154)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(71)
Humans
(53)
Female
(28)
Male
(25)
Gastroenterology & Hepatology
(24)
Middle Aged
(24)
Adult
(18)
Hepatotoxicity
(16)
Aged
(14)
Nursing
(14)
Patients
(14)
Chemical And Drug Induced Liver Injury - Epidemiology
(13)
Hepatitis
(13)
Drug-Induced Liver Injury
(12)
Chemical And Drug Induced Liver Injury - Etiology
(11)
Hepatitis C
(11)
Medicine
(11)
Latin America
(10)
Medicine & Public Health
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury

Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-wide Association Study

Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma

O-7 LIVER TOXICITY OF TYROSINE KINASE INHIBITORS: A DESCRIPTIVE ANALYSIS FROM SLATINDILI NETWORK

Implementation of a re‐linkage to care strategy in patients with chronic hepatitis C who were lost to follow‐up in Latin America

Hepatotoxicidad por esteroides anabólicos androgénicos, reporte de 2 casos en Uruguay

Colangiopatía portal: complicación poco frecuente de la hipertensión portal

Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury

Mixed Infections Unravel Novel HCV Inter-Genotypic Recombinant Forms within the Conserved IRES Region

Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report

P-75 UPDATE OF CLINICO-EPIDEMIOLOGICAL CHARACTERISTICS OF PRIMARY BILIAR CHOLANGITIS IN URUGUAY

Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical Practice

Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries

Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review

Diagnóstico no invasivo de la presencia de várices esofágicas en pacientes cirróticos

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver

Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification

Cirrosis biliar primaria: Aspectos clínico- epidemiológicos en una población uruguaya

Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real‐world experience from HCV‐LALREAN cohort

Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases

Syphilitic hepatitis: should it be added to the algorithm of hepatogram alterations? Report of three cases

Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients

Naturally occurring NS3 resistance-associated variants in hepatitis C virus genotype 1: Their relevance for developing countries

OP-3 CLINICAL PRESENTATION AND CAUSATIVE AGENTS OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY IN URUGUAY: FIRST DECADE OF EXPERIENCE

Suchergebnisse filtern